JP2023544476A5 - - Google Patents
Info
- Publication number
- JP2023544476A5 JP2023544476A5 JP2023510342A JP2023510342A JP2023544476A5 JP 2023544476 A5 JP2023544476 A5 JP 2023544476A5 JP 2023510342 A JP2023510342 A JP 2023510342A JP 2023510342 A JP2023510342 A JP 2023510342A JP 2023544476 A5 JP2023544476 A5 JP 2023544476A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- substituted
- compound according
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026020642A JP2026086696A (ja) | 2020-08-11 | 2026-02-12 | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020108325 | 2020-08-11 | ||
| CNPCT/CN2020/108325 | 2020-08-11 | ||
| PCT/IB2021/059266 WO2022034568A1 (en) | 2020-08-11 | 2021-10-09 | Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026020642A Division JP2026086696A (ja) | 2020-08-11 | 2026-02-12 | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544476A JP2023544476A (ja) | 2023-10-24 |
| JP2023544476A5 true JP2023544476A5 (enExample) | 2024-10-11 |
Family
ID=78179477
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023510342A Pending JP2023544476A (ja) | 2020-08-11 | 2021-10-09 | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 |
| JP2026020642A Pending JP2026086696A (ja) | 2020-08-11 | 2026-02-12 | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026020642A Pending JP2026086696A (ja) | 2020-08-11 | 2026-02-12 | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4196220A1 (enExample) |
| JP (2) | JP2023544476A (enExample) |
| KR (1) | KR20240068583A (enExample) |
| CN (1) | CN116669727B (enExample) |
| AU (1) | AU2021323515A1 (enExample) |
| CA (1) | CA3191452A1 (enExample) |
| IL (1) | IL300525A (enExample) |
| MX (1) | MX2023001812A (enExample) |
| WO (1) | WO2022034568A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114728168B (zh) | 2019-11-15 | 2024-04-09 | 吉利德科学公司 | 三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途 |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| US11702407B2 (en) | 2020-06-03 | 2023-07-18 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| CN117751106A (zh) * | 2021-04-30 | 2024-03-22 | 唯久生物技术(苏州)有限公司 | 作为lpa拮抗剂的新型三唑-吡啶取代的吡咯烷基和四氢-2h-吡喃基乙酸化合物 |
| AU2022273631B2 (en) | 2021-05-11 | 2025-04-17 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| KR20240007233A (ko) | 2021-05-13 | 2024-01-16 | 길리애드 사이언시즈, 인코포레이티드 | Lpa 수용체 길항제 및 이의 용도 |
| US11939318B2 (en) | 2021-12-08 | 2024-03-26 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| TW202342017A (zh) | 2022-02-25 | 2023-11-01 | 美商洛子峰生物有限公司 | 用於治療與ｌｐａ受體活性相關的病狀的化合物及組合物 |
| WO2024022314A1 (zh) * | 2022-07-25 | 2024-02-01 | 武汉人福创新药物研发中心有限公司 | 三氮唑类化合物及其作为lpar1拮抗剂的用途 |
| CN121773091A (zh) * | 2023-09-08 | 2026-03-31 | 西藏海思科制药有限公司 | 杂芳环衍生物的lpar1拮抗剂及其用途 |
| WO2025162421A1 (zh) * | 2024-02-04 | 2025-08-07 | 西藏海思科制药有限公司 | Lpar1拮抗剂及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1364659B1 (en) * | 2001-02-08 | 2009-11-11 | Ono Pharmaceutical Co., Ltd. | Remedies for urinary diseases comprising lpa receptor controlling agents |
| GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| JP5931721B2 (ja) * | 2009-06-16 | 2016-06-08 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ | アシルＣｏＡリゾリン脂質アシルトランスフェラーゼの発現による長鎖オメガ−３及びオメガ−６多価不飽和脂肪酸生合成の改良 |
| US8785442B2 (en) * | 2011-01-30 | 2014-07-22 | Curegenix, Inc. | Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| EP2922823B1 (en) | 2012-11-20 | 2018-10-31 | Merck Sharp & Dohme Corp. | Pyrimidine pde10 inhibitors |
| US20140200215A1 (en) * | 2013-01-15 | 2014-07-17 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
| SG11201507459YA (en) * | 2013-03-15 | 2015-10-29 | Epigen Biosciences Inc | Heterocyclic compounds useful in the treatment of disease |
| CN111712492B (zh) * | 2017-12-19 | 2024-05-31 | 百时美施贵宝公司 | 作为lpa拮抗剂的环己基酸三唑唑类 |
| CA3085561A1 (en) * | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Cyclohexyl acid triazole azines as lpa antagonists |
| WO2019126087A1 (en) * | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Cyclohexyl acid isoxazole azoles as lpa antagonists |
| JP7202383B2 (ja) * | 2017-12-19 | 2023-01-11 | ブリストル－マイヤーズ スクイブ カンパニー | Ｌｐａアンタゴニストとしてのピラゾールｏ－架橋カルバモイルシクロヘキシル酸 |
| ES2946657T3 (es) * | 2018-09-18 | 2023-07-24 | Bristol Myers Squibb Co | Acidos ciclopentílicos como antagonistas de LPA |
-
2021
- 2021-10-09 IL IL300525A patent/IL300525A/en unknown
- 2021-10-09 MX MX2023001812A patent/MX2023001812A/es unknown
- 2021-10-09 CN CN202180067597.XA patent/CN116669727B/zh active Active
- 2021-10-09 CA CA3191452A patent/CA3191452A1/en active Pending
- 2021-10-09 JP JP2023510342A patent/JP2023544476A/ja active Pending
- 2021-10-09 KR KR1020237008152A patent/KR20240068583A/ko active Pending
- 2021-10-09 WO PCT/IB2021/059266 patent/WO2022034568A1/en not_active Ceased
- 2021-10-09 EP EP21791479.5A patent/EP4196220A1/en active Pending
- 2021-10-09 AU AU2021323515A patent/AU2021323515A1/en active Pending
-
2026
- 2026-02-12 JP JP2026020642A patent/JP2026086696A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024543976A5 (enExample) | ||
| JP2024517769A5 (enExample) | ||
| JP2014531434A5 (enExample) | ||
| JP2021508686A5 (enExample) | ||
| JP2022538228A5 (enExample) | ||
| JP2022500470A5 (enExample) | ||
| JP2019094345A5 (enExample) | ||
| JP2019537603A5 (enExample) | ||
| JP2019031560A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| JP2018524339A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2013502431A5 (enExample) | ||
| JP2018536648A5 (enExample) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2016518434A5 (enExample) | ||
| RU2005110061A (ru) | Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина | |
| JP2014513704A5 (enExample) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2009523841A5 (enExample) | ||
| JP2014530900A5 (enExample) | ||
| JP2022500469A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2020500182A5 (enExample) | ||
| JP2020502047A5 (enExample) |